Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Contraception and Contraceptive Drugs

  Free Subscription


Articles published in Obstet Gynecol

Retrieve available abstracts of 138 articles:
HTML format



Single Articles


    April 2021
  1. COLEMAN-MINAHAN K, Ela EJ, White K, Grossman D, et al
    Contraindications to Hormonal Contraception Among Postpartum Women in Texas.
    Obstet Gynecol. 2021 Apr 8. pii: 00006250-990000000-00175.
    PubMed     Abstract available


    March 2021
  2. MEURICE ME, Lovio M, Chang JJ, Perry R, et al
    Contraception Choice Among Those Seeking Abortion for Fetal Indication or Management of Pregnancy Loss.
    Obstet Gynecol. 2021 Mar 10. pii: 00006250-990000000-00125.
    PubMed     Abstract available


    February 2021
  3. AKTURK HK
    Locating Hormone-Releasing Contraceptive Implants Using Near-Infrared Light.
    Obstet Gynecol. 2021 Feb 4. pii: 00006250-990000000-00117.
    PubMed     Abstract available


  4. ROLAND N, Drouin J, Desplas D, Cuenot F, et al
    Effects of the Coronavirus Disease 2019 (COVID-19) Lockdown on the Use of Contraceptives and Ovulation Inductors in France.
    Obstet Gynecol. 2021 Feb 4. pii: 00006250-990000000-00100.
    PubMed    


    January 2021

  5. Options for Prevention and Management of Menstrual Bleeding in Adolescent Patients Undergoing Cancer Treatment: ACOG Committee Opinion, Number 817.
    Obstet Gynecol. 2021;137:e7-e15.
    PubMed     Abstract available


    December 2020
  6. GOLDMAN AR, Porsch L, Hintermeister A, Dragoman M, et al
    Transcutaneous Electrical Nerve Stimulation to Reduce Pain With Medication Abortion: A Randomized Controlled Trial.
    Obstet Gynecol. 2020 Dec 3. doi: 10.1097/AOG.0000000000004208.
    PubMed     Abstract available


    November 2020

  7. Gynecologic Considerations for Adolescents and Young Women With Cardiac Conditions: ACOG Committee Opinion, Number 813.
    Obstet Gynecol. 2020;136:e90-e99.
    PubMed     Abstract available



  8. Gynecologic Considerations for Adolescents and Young Women With Cardiac Conditions: ACOG Committee Opinion Summary, Number 813.
    Obstet Gynecol. 2020;136:1072-1073.
    PubMed     Abstract available


    October 2020
  9. FERRIES-ROWE E, Corey E, Archer JS
    Primary Dysmenorrhea: Diagnosis and Therapy.
    Obstet Gynecol. 2020 Oct 8. doi: 10.1097/AOG.0000000000004096.
    PubMed     Abstract available



  10. Medication Abortion Up to 70 Days of Gestation: ACOG Practice Bulletin Summary, Number 225.
    Obstet Gynecol. 2020;136:855-858.
    PubMed     Abstract available


    September 2020
  11. BERKLEY HH, Greene HL, Wittenberger MD
    Mifepristone Combination Therapy Compared With Misoprostol Monotherapy for the Management of Miscarriage: A Cost-Effectiveness Analysis.
    Obstet Gynecol. 2020 Sep 10. doi: 10.1097/AOG.0000000000004063.
    PubMed     Abstract available


    August 2020
  12. CREININ MD, Grossman DA
    Medication Abortion Up to 70 Days of Gestation.
    Obstet Gynecol. 2020 Aug 12. doi: 10.1097/AOG.0000000000004082.
    PubMed     Abstract available


  13. LEININGER WM, Gupta P
    One Hundred Years of Women's Suffrage: Health Care Advocacy, and Why We Vote.
    Obstet Gynecol. 2020;136:349-353.
    PubMed     Abstract available


    July 2020
  14. EDELMAN AB, Kaneshiro B, Simmons KB, Hauschildt JL, et al
    Treatment of Unfavorable Bleeding Patterns in Contraceptive Implant Users: A Randomized Controlled Trial.
    Obstet Gynecol. 2020 Jul 9. doi: 10.1097/AOG.0000000000003896.
    PubMed     Abstract available


    June 2020
  15. BARBIERI JS, Mitra N, Margolis DJ, Harper CC, et al
    Influence of Contraception Class on Incidence and Severity of Acne Vulgaris.
    Obstet Gynecol. 2020;135:1306-1312.
    PubMed     Abstract available


  16. SPOTNITZ ME, Natarajan K, Ryan PB, Westhoff CL, et al
    In Reply.
    Obstet Gynecol. 2020;135:1487.
    PubMed    


  17. SEL G, Yasar O, Aynali B, Dincer F, et al
    Relative Risk of Cervical Neoplasms Among Copper and Levonorgestrel-Releasing Intrauterine System Users.
    Obstet Gynecol. 2020;135:1486-1487.
    PubMed    


  18. SIMON JA, Al-Hendy A, Archer DF, Barnhart KT, et al
    Elagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas.
    Obstet Gynecol. 2020;135:1313-1326.
    PubMed     Abstract available


  19. FLOYD JL, Beasley AD, Swaim LS, Turrentine MA, et al
    Association of Immediate Postpartum Etonogestrel Implant Insertion and Venous Thromboembolism.
    Obstet Gynecol. 2020;135:1275-1280.
    PubMed     Abstract available


    May 2020

  20. Gynecologic Management of Adolescents and Young Women With Seizure Disorders: ACOG Committee Opinion, Number 806.
    Obstet Gynecol. 2020;135:e213-e220.
    PubMed     Abstract available



  21. Gynecologic Management of Adolescents and Young Women With Seizure Disorders: ACOG Committee Opinion Summary, Number 806.
    Obstet Gynecol. 2020;135:1242-1243.
    PubMed     Abstract available


    April 2020
  22. LATHROP E, Hurst S, Mendoza Z, Zapata LB, et al
    Final Program Data and Factors Associated With Long-Acting Reversible Contraception Removal: The Zika Contraception Access Network.
    Obstet Gynecol. 2020 Apr 9. doi: 10.1097/AOG.0000000000003835.
    PubMed     Abstract available


  23. DARWIN KC, Johnson CT
    Desired Sterilization Procedure at the Time of Cesarean Delivery According to Insurance Status.
    Obstet Gynecol. 2020;135:976.
    PubMed    


  24. CREININ MD, Hou MY, Dalton L, Steward R, et al
    In Reply.
    Obstet Gynecol. 2020;135:970-971.
    PubMed    


  25. VALLEY MT
    Mifepristone Antagonization With Progesterone to Prevent Medical Abortion: A Randomized Controlled Trial.
    Obstet Gynecol. 2020;135:970.
    PubMed    


  26. BUTTERFIELD-KALK CR
    Mifepristone Antagonization With Progesterone to Prevent Medical Abortion: A Randomized Controlled Trial.
    Obstet Gynecol. 2020;135:970.
    PubMed    


  27. DELGADO G, Davenport M, Harrison M
    Mifepristone Antagonization With Progesterone to Prevent Medical Abortion: A Randomized Controlled Trial.
    Obstet Gynecol. 2020;135:969-970.
    PubMed    


    March 2020
  28. STEINBERG JR, Harrison EY, Boudreaux M
    Psychosocial Factors Associated With Postpartum Contraceptive Method Use After an Unintended Birth.
    Obstet Gynecol. 2020 Mar 10. doi: 10.1097/AOG.0000000000003745.
    PubMed     Abstract available


    February 2020
  29. SPOTNITZ ME, Natarajan K, Ryan PB, Westhoff CL, et al
    Relative Risk of Cervical Neoplasms Among Copper and Levonorgestrel-Releasing Intrauterine System Users.
    Obstet Gynecol. 2020 Feb 9. doi: 10.1097/AOG.0000000000003656.
    PubMed     Abstract available


  30. MACAFEE LK, Harfmann RF, Cannon LM, Kolenic G, et al
    Sexual and Reproductive Health Characteristics of Women in Substance Use Treatment in Michigan.
    Obstet Gynecol. 2020;135:361-369.
    PubMed     Abstract available


    January 2020

  31. Pharmacist Provision of Hormonal Contraception in the Oregon Medicaid Population: Correction.
    Obstet Gynecol. 2020;135:222.
    PubMed    


    December 2019
  32. CREININ MD, Hou MY, Dalton L, Steward R, et al
    Mifepristone Antagonization With Progesterone to Prevent Medical Abortion: A Randomized Controlled Trial.
    Obstet Gynecol. 2019 Dec 5. doi: 10.1097/AOG.0000000000003620.
    PubMed     Abstract available


    October 2019

  33. Over-the-Counter Access to Hormonal Contraception: ACOG Committee Opinion, Number 788.
    Obstet Gynecol. 2019;134:e96-e105.
    PubMed     Abstract available



  34. Over-the-Counter Access to Hormonal Contraception: ACOG Committee Opinion Summary, Number 788.
    Obstet Gynecol. 2019;134:886-887.
    PubMed     Abstract available


    September 2019
  35. LAZORWITZ A, Aquilante CL, Dindinger E, Harrison M, et al
    Relationship Between Etonogestrel Concentrations and Bleeding Patterns in Contraceptive Implant Users.
    Obstet Gynecol. 2019 Sep 10. doi: 10.1097/AOG.0000000000003452.
    PubMed     Abstract available


  36. MATULICH MC, Chen MJ, Schimmoeller NR, Hsia JK, et al
    Referral Center Experience With Nonpalpable Contraceptive Implant Removals.
    Obstet Gynecol. 2019 Sep 10. doi: 10.1097/AOG.0000000000003457.
    PubMed     Abstract available



  37. Screening and Management of Bleeding Disorders in Adolescents With Heavy Menstrual Bleeding: ACOG COMMITTEE OPINION, Number 785.
    Obstet Gynecol. 2019;134:e71-e83.
    PubMed     Abstract available



  38. Screening and Management of Bleeding Disorders in Adolescents With Heavy Menstrual Bleeding: ACOG COMMITTEE OPINION SUMMARY, Number 785.
    Obstet Gynecol. 2019;134:658-659.
    PubMed     Abstract available


    August 2019
  39. RAINE-BENNETT T, Chandra M, Armstrong MA, Alexeeff S, et al
    Depot Medroxyprogesterone Acetate, Oral Contraceptive, Intrauterine Device Use, and Fracture Risk.
    Obstet Gynecol. 2019 Aug 7. doi: 10.1097/AOG.0000000000003414.
    PubMed     Abstract available


  40. HADDAD LB, Wall KM, Tote K, Kilembe W, et al
    Hormonal Contraception and Vaginal Infections Among Couples Who Are Human Immunodeficiency Virus Serodiscordant in Lusaka, Zambia.
    Obstet Gynecol. 2019 Aug 7. doi: 10.1097/AOG.0000000000003404.
    PubMed     Abstract available


    July 2019

  41. Association of Pharmacist Prescription of Hormonal Contraception With Unintended Pregnancies and Medicaid Costs: Correction.
    Obstet Gynecol. 2019;134:182.
    PubMed    


    June 2019
  42. SCHWARTZ AR, Russell K, Gray BA
    Approaches to Vaginal Bleeding and Contraceptive Counseling in Transgender and Gender Nonbinary Patients.
    Obstet Gynecol. 2019 Jun 11. doi: 10.1097/AOG.0000000000003308.
    PubMed     Abstract available


  43. LU CF, Vargas SE, Guillen M, Ramirez JJ, et al
    A Qualitative Study of the Contraceptive Effect on Women's Sexual Experiences: Beyond Hormonal Effects.
    Obstet Gynecol. 2019 Jun 11. doi: 10.1097/AOG.0000000000003331.
    PubMed     Abstract available



  44. ACOG Practice Bulletin No. 206: Use of Hormonal Contraception in Women With Coexisting Medical Conditions: Correction.
    Obstet Gynecol. 2019;133:1288.
    PubMed    



  45. ACOG Practice Bulletin No. 206: Use of Hormonal Contraception in Women With Coexisting Medical Conditions: Correction.
    Obstet Gynecol. 2019;133:1288.
    PubMed    


  46. RODRIGUEZ MI, Hersh A, Anderson LB, Hartung DM, et al
    Association of Pharmacist Prescription of Hormonal Contraception With Unintended Pregnancies and Medicaid Costs.
    Obstet Gynecol. 2019;133:1238-1246.
    PubMed     Abstract available


  47. ANDERSON L, Hartung DM, Middleton L, Rodriguez MI, et al
    Pharmacist Provision of Hormonal Contraception in the Oregon Medicaid Population.
    Obstet Gynecol. 2019;133:1231-1237.
    PubMed     Abstract available


  48. AINSWORTH AJ, Baumgarten SC, Bakkum-Gamez JN, Vachon CM, et al
    Tubal Ligation and Age at Natural Menopause.
    Obstet Gynecol. 2019;133:1247-1254.
    PubMed     Abstract available


    May 2019
  49. RODRIGUEZ MI, Hersh A, Anderson LB, Hartung DM, et al
    Association of Pharmacist Prescription of Hormonal Contraception With Unintended Pregnancies and Medicaid Costs.
    Obstet Gynecol. 2019 May 9. doi: 10.1097/AOG.0000000000003265.
    PubMed     Abstract available


  50. ANDERSON L, Hartung DM, Middleton L, Rodriguez MI, et al
    Pharmacist Provision of Hormonal Contraception in the Oregon Medicaid Population.
    Obstet Gynecol. 2019 May 9. doi: 10.1097/AOG.0000000000003286.
    PubMed     Abstract available


    April 2019
  51. RESNIK JL
    What Is New in Contraception?: Best Articles From the Past Year.
    Obstet Gynecol. 2019 Apr 5. doi: 10.1097/AOG.0000000000003237.
    PubMed     Abstract available


  52. GREENE MZ, Carpenter E, Hendrick CE, Haider S, et al
    Sexual Minority Women's Experiences With Sexual Identity Disclosure in Contraceptive Care.
    Obstet Gynecol. 2019 Apr 5. doi: 10.1097/AOG.0000000000003222.
    PubMed     Abstract available


  53. HATFIELD JL
    Ulipristal Acetate for Symptomatic Uterine Leiomyomas: Neither the Long-Awaited Panacea, nor the Opening of Pandora's Box.
    Obstet Gynecol. 2019 Apr 5. doi: 10.1097/AOG.0000000000003238.
    PubMed    



  54. ACOG Committee Opinion No. 774: Opportunistic Salpingectomy as a Strategy for Epithelial Ovarian Cancer Prevention.
    Obstet Gynecol. 2019;133:e279-e284.
    PubMed     Abstract available


    March 2019
  55. COPE AG, Mara KC, Weaver AL, Casey PM, et al
    Postpartum Contraception Usage Among Somali Women in Olmsted County, Minnesota.
    Obstet Gynecol. 2019 Mar 11. doi: 10.1097/AOG.0000000000003154.
    PubMed     Abstract available


  56. LAZORWITZ A, Aquilante CL, Oreschak K, Sheeder J, et al
    Influence of Genetic Variants on Steady-State Etonogestrel Concentrations Among Contraceptive Implant Users.
    Obstet Gynecol. 2019 Mar 11. doi: 10.1097/AOG.0000000000003189.
    PubMed     Abstract available


  57. WONG S, Naresh A
    Etonogestrel Subdermal Implant-Associated Regression of Endometrial Intraepithelial Neoplasia.
    Obstet Gynecol. 2019 Mar 11. doi: 10.1097/AOG.0000000000003152.
    PubMed     Abstract available


  58. SUDHOF L, Shah NT
    In Pursuit of Value-Based Maternity Care.
    Obstet Gynecol. 2019;133:541-551.
    PubMed     Abstract available


  59. TEPPER NK, Jeng G, Curtis KM, Boutot ME, et al
    Venous Thromboembolism Among Women Initiating Depot Medroxyprogesterone Acetate Immediately Postpartum.
    Obstet Gynecol. 2019;133:533-540.
    PubMed     Abstract available


  60. BENLOLO S, Papillon-Smith J, Murji A
    Ulipristal Acetate for Disseminated Peritoneal Leiomyomatosis.
    Obstet Gynecol. 2019;133:434-436.
    PubMed     Abstract available



  61. ACOG Practice Bulletin No. 208: Benefits and Risks of Sterilization.
    Obstet Gynecol. 2019;133:e194-e207.
    PubMed     Abstract available



  62. ACOG Practice Bulletin No. 208 Summary: Benefits and Risks of Sterilization.
    Obstet Gynecol. 2019;133:592-594.
    PubMed     Abstract available


    February 2019
  63. GROSSMAN D, Grindlay K, Altshuler AL, Schulkin J, et al
    Induced Abortion Provision Among a National Sample of Obstetrician-Gynecologists.
    Obstet Gynecol. 2019 Feb 4. doi: 10.1097/AOG.0000000000003110.
    PubMed     Abstract available



  64. ACOG Practice Bulletin No. 206: Use of Hormonal Contraception in Women With Coexisting Medical Conditions.
    Obstet Gynecol. 2019;133:e128-e150.
    PubMed     Abstract available



  65. ACOG Practice Bulletin No. 206 Summary: Use of Hormonal Contraception in Women With Coexisting Medical Conditions.
    Obstet Gynecol. 2019;133:396-399.
    PubMed     Abstract available


  66. MAO J, Guiahi M, Chudnoff S, Schlegel P, et al
    Seven-Year Outcomes After Hysteroscopic and Laparoscopic Sterilizations.
    Obstet Gynecol. 2019;133:323-331.
    PubMed     Abstract available


  67. DIANAT S, Fox E, Ahrens KA, Upadhyay UD, et al
    Side Effects and Health Benefits of Depot Medroxyprogesterone Acetate: A Systematic Review.
    Obstet Gynecol. 2019;133:332-341.
    PubMed     Abstract available


    January 2019

  68. ACOG Committee Opinion No. 762: Prepregnancy Counseling.
    Obstet Gynecol. 2019;133:e78-e89.
    PubMed     Abstract available



  69. ACOG Committee Opinion No. 762 Summary: Prepregnancy Counseling.
    Obstet Gynecol. 2019;133:228-230.
    PubMed     Abstract available


  70. THORNE NB, Soderborg TK, Glover JJ, Hoffecker L, et al
    Reproductive Health Care in Catholic Facilities: A Scoping Review.
    Obstet Gynecol. 2019;133:105-115.
    PubMed     Abstract available


    December 2018
  71. TEAL SB, Turok DK, Chen BA, Kimble T, et al
    Five-Year Contraceptive Efficacy and Safety of a Levonorgestrel 52-mg Intrauterine System.
    Obstet Gynecol. 2018 Dec 4. doi: 10.1097/AOG.0000000000003034.
    PubMed     Abstract available


  72. ANDERSON S, Frerichs L, Kaysin A, Wheeler SB, et al
    Effects of Two Educational Posters on Contraceptive Knowledge and Intentions: A Randomized Controlled Trial.
    Obstet Gynecol. 2018 Dec 4. doi: 10.1097/AOG.0000000000003012.
    PubMed     Abstract available



  73. ACOG Committee Opinion No. 760: Dysmenorrhea and Endometriosis in the Adolescent.
    Obstet Gynecol. 2018;132:e249-e258.
    PubMed     Abstract available



  74. ACOG Committee Opinion No. 760 Summary: Dysmenorrhea and Endometriosis in the Adolescent.
    Obstet Gynecol. 2018;132:1517-1518.
    PubMed     Abstract available


    November 2018
  75. GYLLENBERG FK, Saloranta TH, But A, Gissler M, et al
    Induced Abortion in a Population Entitled to Free-of-Charge Long-Acting Reversible Contraception.
    Obstet Gynecol. 2018 Nov 5. doi: 10.1097/AOG.0000000000002966.
    PubMed     Abstract available



  76. ACOG Practice Bulletin No. 200 Summary: Early Pregnancy Loss.
    Obstet Gynecol. 2018;132:1311-1313.
    PubMed     Abstract available


    October 2018
  77. CARR BR, Stewart EA, Archer DF, Al-Hendy A, et al
    Elagolix Alone or With Add-Back Therapy in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas: A Randomized Controlled Trial.
    Obstet Gynecol. 2018 Oct 5. doi: 10.1097/AOG.0000000000002933.
    PubMed     Abstract available


  78. SONALKAR S, Hunter T, Gurney EP, McAllister A, et al
    A Decision Analysis Model of 1-Year Effectiveness of Intended Postplacental Compared With Intended Delayed Postpartum Intrauterine Device Insertion.
    Obstet Gynecol. 2018 Oct 5. doi: 10.1097/AOG.0000000000002926.
    PubMed     Abstract available


  79. LIU JH, Soper D, Lukes A, Gee P, et al
    Ulipristal Acetate for Treatment of Uterine Leiomyomas: A Randomized Controlled Trial.
    Obstet Gynecol. 2018 Oct 5. doi: 10.1097/AOG.0000000000002942.
    PubMed     Abstract available


    August 2018

  80. Early Pregnancy Loss.
    Obstet Gynecol. 2018 Aug 28. doi: 10.1097/AOG.0000000000002899.
    PubMed     Abstract available


  81. MONTAGUE M, Ascha M, Wilkinson B, Verbus E, et al
    Role of Bridge Contraception in Postpartum Long-Acting Reversible Contraception and Sterilization Fulfillment Rates.
    Obstet Gynecol. 2018 Aug 6. doi: 10.1097/AOG.0000000000002803.
    PubMed     Abstract available


  82. WU J, Zhang J, Mitra M, Parish SL, et al
    Provision of Moderately and Highly Effective Reversible Contraception to Insured Women With Intellectual and Developmental Disabilities.
    Obstet Gynecol. 2018 Aug 6. doi: 10.1097/AOG.0000000000002777.
    PubMed     Abstract available


  83. HILLARD PJA
    Contraception for Women With Intellectual and Developmental Disabilities: Reproductive Justice.
    Obstet Gynecol. 2018 Aug 6. doi: 10.1097/AOG.0000000000002814.
    PubMed    



  84. ACOG Committee Opinion No. 747: Gynecologic Issues in Children and Adolescent Cancer Patients and Survivors.
    Obstet Gynecol. 2018;132:e67-e77.
    PubMed     Abstract available


    July 2018
  85. ROTTENSTREICH A, Bauman D, Kalish Y
    Abnormal Vaginal Bleeding in Women Desiring Contraception Who Are Taking Anticoagulation Therapy.
    Obstet Gynecol. 2018;132:216-217.
    PubMed    


  86. ILLINGWORTH BJG, Hirsch M, Duffy JMN
    Ulipristal Acetate for Treatment of Symptomatic Uterine Leiomyomas: A Randomized Controlled Trial.
    Obstet Gynecol. 2018;132:215.
    PubMed    


    May 2018
  87. AKERS AY, Harding J, Perriera LK, Schreiber C, et al
    Satisfaction With the Intrauterine Device Insertion Procedure Among Adolescent and Young Adult Women.
    Obstet Gynecol. 2018 May 7. doi: 10.1097/AOG.0000000000002596.
    PubMed     Abstract available



  88. ACOG Committee Opinion No. 735: Adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices.
    Obstet Gynecol. 2018;131:e130-e139.
    PubMed     Abstract available



  89. ACOG Committee Opinion No. 735 Summary: Adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices.
    Obstet Gynecol. 2018;131:947-948.
    PubMed     Abstract available


    April 2018
  90. BATRA P, Rafie S, Zhang Z, Singh AV, et al
    An Evaluation of the Implementation of Pharmacist-Prescribed Hormonal Contraceptives in California.
    Obstet Gynecol. 2018 Apr 6. doi: 10.1097/AOG.0000000000002572.
    PubMed     Abstract available


  91. HEISEL E, Kolenic GE, Moniz MM, Kobernik EK, et al
    Intrauterine Device Insertion Before and After Mandated Health Care Coverage: The Importance of Baseline Costs.
    Obstet Gynecol. 2018 Apr 6. doi: 10.1097/AOG.0000000000002567.
    PubMed     Abstract available


    March 2018
  92. BONNINGTON A, Autry AM
    Abnormal Vaginal Bleeding in Women Desiring Contraception Who Are Taking Anticoagulation Therapy.
    Obstet Gynecol. 2018 Mar 8. doi: 10.1097/AOG.0000000000002518.
    PubMed     Abstract available


  93. LOHR PA, Starling JE, Scott JG, Aiken ARA, et al
    Simultaneous Compared With Interval Medical Abortion Regimens Where Home Use Is Restricted.
    Obstet Gynecol. 2018 Mar 8. doi: 10.1097/AOG.0000000000002536.
    PubMed     Abstract available


    February 2018
  94. EVANS ML, Espey E, Ogburn T, Zite NB, et al
    Use of Long-Acting Reversible Contraception by Obstetrics and Gynecology Residents: An Examination of Access for All Women.
    Obstet Gynecol. 2018 Feb 5. doi: 10.1097/AOG.0000000000002489.
    PubMed     Abstract available


  95. SIMON JA, Catherino W, Segars JH, Blakesley RE, et al
    Ulipristal Acetate for Treatment of Symptomatic Uterine Leiomyomas: A Randomized Controlled Trial.
    Obstet Gynecol. 2018 Feb 5. doi: 10.1097/AOG.0000000000002462.
    PubMed     Abstract available


    January 2018
  96. BRANDI K, Morgan JR, Paasche-Orlow MK, Perkins RB, et al
    Obstetric Outcomes After Failed Hysteroscopic and Laparoscopic Sterilization Procedures.
    Obstet Gynecol. 2018 Jan 9. doi: 10.1097/AOG.0000000000002446.
    PubMed     Abstract available


  97. STUART GS, Ramesh SS
    Interval Female Sterilization.
    Obstet Gynecol. 2018;131:117-124.
    PubMed     Abstract available


    December 2017
  98. PAL N, Broaddus RR, Urbauer DL, Balakrishnan N, et al
    Treatment of Low-Risk Endometrial Cancer and Complex Atypical Hyperplasia With the Levonorgestrel-Releasing Intrauterine Device.
    Obstet Gynecol. 2017 Dec 4. doi: 10.1097/AOG.0000000000002390.
    PubMed     Abstract available


    November 2017
  99. BIGGS MA, Taylor D, Upadhyay UD
    Role of Insurance Coverage in Contraceptive Use After Abortion.
    Obstet Gynecol. 2017 Nov 3. doi: 10.1097/AOG.0000000000002361.
    PubMed     Abstract available


  100. CORTESSIS VK, Barrett M, Brown Wade N, Enebish T, et al
    Intrauterine Device Use and Cervical Cancer Risk: A Systematic Review and Meta-analysis.
    Obstet Gynecol. 2017 Nov 3. doi: 10.1097/AOG.0000000000002307.
    PubMed     Abstract available



  101. Practice Bulletin No. 186: Long-Acting Reversible Contraception: Implants and Intrauterine Devices.
    Obstet Gynecol. 2017;130:e251-e269.
    PubMed     Abstract available



  102. Practice Bulletin No. 186 Summary: Long-Acting Reversible Contraception: Implants and Intrauterine Devices.
    Obstet Gynecol. 2017;130:1173-1175.
    PubMed     Abstract available


    October 2017
  103. MONIZ MH, Gavin LE, Dalton VK
    Performance Measures for Contraceptive Care: A New Tool to Enhance Access to Contraception.
    Obstet Gynecol. 2017 Oct 6. doi: 10.1097/AOG.0000000000002314.
    PubMed     Abstract available


  104. MENKE MN, King WC, White GE, Gosman GG, et al
    Contraception and Conception After Bariatric Surgery.
    Obstet Gynecol. 2017 Oct 6. doi: 10.1097/AOG.0000000000002323.
    PubMed     Abstract available


    September 2017
  105. CHEN MJ, Hou MY, Hsia JK, Cansino CD, et al
    Long-Acting Reversible Contraception Initiation With a 2- to 3-Week Compared With a 6-Week Postpartum Visit.
    Obstet Gynecol. 2017 Sep 5. doi: 10.1097/AOG.0000000000002246.
    PubMed     Abstract available


  106. MONIZ MH, Spector-Bagdady K, Heisler M, Harris LH, et al
    Inpatient Postpartum Long-Acting Reversible Contraception: Care That Promotes Reproductive Justice.
    Obstet Gynecol. 2017 Sep 5. doi: 10.1097/AOG.0000000000002262.
    PubMed     Abstract available


    August 2017
  107. ISEYEMI A, Zhao Q, McNicholas C, Peipert JF, et al
    Socioeconomic Status As a Risk Factor for Unintended Pregnancy in the Contraceptive CHOICE Project.
    Obstet Gynecol. 2017 Aug 4. doi: 10.1097/AOG.0000000000002189.
    PubMed     Abstract available



  108. Committee Opinion No. 710: Counseling Adolescents About Contraception.
    Obstet Gynecol. 2017;130:e74-e80.
    PubMed     Abstract available



  109. Committee Opinion No. 710 Summary: Counseling Adolescents About Contraception.
    Obstet Gynecol. 2017;130:486-487.
    PubMed     Abstract available


    July 2017
  110. POTTER JE, Coleman-Minahan K, White K, Powers DA, et al
    Contraception After Delivery Among Publicly Insured Women in Texas: Use Compared With Preference.
    Obstet Gynecol. 2017 Jul 7. doi: 10.1097/AOG.0000000000002136.
    PubMed     Abstract available



  111. Committee Opinion No 707: Access to Emergency Contraception.
    Obstet Gynecol. 2017;130:e48-e52.
    PubMed     Abstract available



  112. Committee Opinion No. 707 Summary: Access to Emergency Contraception.
    Obstet Gynecol. 2017;130:251-252.
    PubMed     Abstract available


    June 2017
  113. KRASHIN JW, Stuart GS, Garrett J, Spector H, et al
    Contraception Insurance Coverage and Receipt of Long-Acting Reversible Contraception or Depot Medroxyprogesterone Acetate on the Day of Abortion.
    Obstet Gynecol. 2017 Jun 6. doi: 10.1097/AOG.0000000000002070.
    PubMed     Abstract available


  114. CARMO LSMP, Braga GC, Ferriani RA, Quintana SM, et al
    Timing of Etonogestrel-Releasing Implants and Growth of Breastfed Infants: A Randomized Controlled Trial.
    Obstet Gynecol. 2017 Jun 6. doi: 10.1097/AOG.0000000000002092.
    PubMed     Abstract available


  115. MCHUGH KW, Tucker Edmonds B, Ferries-Rowe E, Haas DM, et al
    Implementing Immediate Postpartum Long-Acting Reversible Contraception Programs.
    Obstet Gynecol. 2017;129:1136-1137.
    PubMed    


    May 2017
  116. MONIZ MH, Chang T, Heisler M, Admon L, et al
    Inpatient Postpartum Long-Acting Reversible Contraception and Sterilization in the United States, 2008-2013.
    Obstet Gynecol. 2017 May 5. doi: 10.1097/AOG.0000000000001970.
    PubMed     Abstract available



  117. Committee Opinion No 699: Adolescent Pregnancy, Contraception, and Sexual Activity.
    Obstet Gynecol. 2017;129:e142-e149.
    PubMed     Abstract available



  118. Committee Opinion No. 699: Adolescent Pregnancy, Contraception, and Sexual Activity.
    Obstet Gynecol. 2017;129:965-966.
    PubMed     Abstract available


  119. CHESCHEIR NC
    Worldwide Abortion Rates and Access to Contraception.
    Obstet Gynecol. 2017;129:783-785.
    PubMed    


    April 2017
  120. CHESCHEIR NC
    Worldwide Abortion Rates and Access to Contraception: Speak Up Against the Global Gag Rule.
    Obstet Gynecol. 2017 Apr 4. doi: 10.1097/AOG.0000000000002028.
    PubMed    


  121. ERICKSON AK, Nelson DA, Shaw JG, Loftus PD, et al
    Long-Acting Reversible Contraceptive Placement Among Active-Duty U.S. Army Servicewomen.
    Obstet Gynecol. 2017 Apr 4. doi: 10.1097/AOG.0000000000001971.
    PubMed     Abstract available



  122. Committee Opinion No. 695: Sterilization of Women: Ethical Issues and Considerations.
    Obstet Gynecol. 2017;129:e109-e116.
    PubMed     Abstract available



  123. Committee Opinion No 695 Summary: Sterilization of Women: Ethical Issues and Considerations.
    Obstet Gynecol. 2017;129:775-776.
    PubMed     Abstract available


    March 2017
  124. DARNEY BG, Aiken AR, Kung S
    Access to Contraception in the Context of Zika: Health System Challenges and Responses.
    Obstet Gynecol. 2017 Mar 6. doi: 10.1097/AOG.0000000000001914.
    PubMed     Abstract available


  125. GOYAL V, Canfield C, Aiken AR, Dermish A, et al
    Postabortion Contraceptive Use and Continuation When Long-Acting Reversible Contraception Is Free.
    Obstet Gynecol. 2017 Mar 6. doi: 10.1097/AOG.0000000000001926.
    PubMed     Abstract available


    February 2017
  126. YANG YT, Sawicki NN
    Pharmacies' Duty to Dispense Emergency Contraception: A Discussion of Religious Liberty.
    Obstet Gynecol. 2017 Feb 6. doi: 10.1097/AOG.0000000000001894.
    PubMed     Abstract available


    January 2017
  127. WALTER JR, Ghobadi CW, Hayman E, Xu S, et al
    Hysteroscopic Sterilization With Essure: Summary of the U.S. Food and Drug Administration Actions and Policy Implications for Postmarketing Surveillance.
    Obstet Gynecol. 2017;129:10-19.
    PubMed     Abstract available


  128. SCHNATZ PF, Jiang X, Aragaki AK, Nudy M, et al
    Effects of Calcium, Vitamin D, and Hormone Therapy on Cardiovascular Disease Risk Factors in the Women's Health Initiative: A Randomized Controlled Trial.
    Obstet Gynecol. 2017;129:121-129.
    PubMed     Abstract available



  129. Clinical Updates in Women's Health Care Summary: Liver Disease: Reproductive Considerations.
    Obstet Gynecol. 2017;129:236.
    PubMed     Abstract available


    December 2016
  130. HOFLER LG, Cordes S, Cwiak CA, Goedken P, et al
    Implementing Immediate Postpartum Long-Acting Reversible Contraception Programs.
    Obstet Gynecol. 2016.
    PubMed     Abstract available


    October 2016
  131. HIGGINS JA, Sanders JN, Palta M, Turok DK, et al
    Women's Sexual Function, Satisfaction, and Perceptions After Starting Long-Acting Reversible Contraceptives.
    Obstet Gynecol. 2016.
    PubMed     Abstract available


  132. SCOCCIA B
    What Is New in Polycystic Ovary Syndrome?: Best Articles From the Past Year.
    Obstet Gynecol. 2016.
    PubMed     Abstract available


  133. ABBAS DF, Blum J, Ngoc NT, Nga NT, et al
    Simultaneous Administration Compared With a 24-Hour Mifepristone-Misoprostol Interval in Second-Trimester Abortion: A Randomized Controlled Trial.
    Obstet Gynecol. 2016.
    PubMed     Abstract available


    September 2016
  134. RAYMOND EG, Weaver MA, Louie KS, Tan YL, et al
    Effects of Depot Medroxyprogesterone Acetate Injection Timing on Medical Abortion Efficacy and Repeat Pregnancy: A Randomized Controlled Trial.
    Obstet Gynecol. 2016.
    PubMed     Abstract available


    August 2016

  135. Adjunctive Social Media for More Effective Contraceptive Counseling: A Randomized Controlled Trial: Correction.
    Obstet Gynecol. 2016;128:411.
    PubMed    



  136. Committee Opinion No. 668: Menstrual Manipulation for Adolescents With Physical and Developmental Disabilities.
    Obstet Gynecol. 2016;128:e20-5.
    PubMed     Abstract available



  137. Committee Opinion No. 668 Summary: Menstrual Manipulation for Adolescents With Physical and Developmental Disabilities.
    Obstet Gynecol. 2016;128:418-9.
    PubMed     Abstract available


    May 2016
  138. MOGLIA ML, Nguyen HV, Chyjek K, Chen KT, et al
    Evaluation of Smartphone Menstrual Cycle Tracking Applications Using an Adapted APPLICATIONS Scoring System.
    Obstet Gynecol. 2016.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Contraception and Contraceptive Drugs is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: